Avidity biosciences to participate in upcoming investor conferences

San diego , aug. 28, 2024 /prnewswire/ -- avidity biosciences, inc. (nasdaq: rna), a biopharmaceutical company committed to delivering a new class of rna therapeutics called antibody oligonucleotide conjugates (aocs™), today announced that avidity management will be participating in the following upcoming conferences: wells fargo 2024 healthcare conference on september 4 at 5:00 a.m. pt / 8:00 a.m.
RNA Ratings Summary
RNA Quant Ranking